139 related articles for article (PubMed ID: 6136141)
1. Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation with clonidine.
Massara F; Limone P; Cagliero E; Tagliabue M; Isaia GC; Molinatti GM
Acta Endocrinol (Copenh); 1983 Jul; 103(3):371-5. PubMed ID: 6136141
[TBL] [Abstract][Full Text] [Related]
2. Naloxone enhances the increase in plasma growth hormone induced by alpha 2-adrenergic stimulation in healthy males.
Bramnert M; Hökfelt B
Acta Endocrinol (Copenh); 1987 Feb; 114(2):308-13. PubMed ID: 2881420
[TBL] [Abstract][Full Text] [Related]
3. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
Bramnert M; Hökfelt B
J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
[TBL] [Abstract][Full Text] [Related]
4. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
[TBL] [Abstract][Full Text] [Related]
5. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intravenous administration.
Chapman IM; Willoughby JO
Neuroendocrinology; 1993 May; 57(5):912-20. PubMed ID: 8105397
[TBL] [Abstract][Full Text] [Related]
6. [Naloxone doesn't determine the response of growth hormone to clonidine in obese patients].
Satta MA; Castelli A; Maussier ML; Scoppola A; Valenza V; Saletnich I; Monaco F; Roche J
C R Seances Soc Biol Fil; 1989; 183(4):337-41. PubMed ID: 2533520
[TBL] [Abstract][Full Text] [Related]
7. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
Kimber J; Sivenandan M; Watson L; Mathias CJ
Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
[TBL] [Abstract][Full Text] [Related]
8. The effect of clonidine on hormone release mediated through activation of opiate receptors.
Baranowska B
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1113-7. PubMed ID: 1964578
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha 2-adrenergic agonist clonidine on plasma growth hormone and insulin-like growth factor-I concentrations in barrows.
Ozawa A; Johke T; Hodate K
Endocr J; 1995 Oct; 42(5):669-73. PubMed ID: 8574291
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intrahypothalamic administration.
Chapman IM; Kapoor R; Willoughby JO
Neuroendocrinology; 1993 May; 57(5):921-7. PubMed ID: 8105398
[TBL] [Abstract][Full Text] [Related]
11. Beta-endorphin mediates clonidine stimulated growth hormone release.
Bruhn TO; Tresco PA; Mueller GP; Jackson IM
Neuroendocrinology; 1989 Oct; 50(4):460-3. PubMed ID: 2572990
[TBL] [Abstract][Full Text] [Related]
12. Effect of naloxone on the growth hormone response to clonidine in normal women during the mid-luteal phase.
Phipps WR; Campbell BF; Pescovitz OH
Psychoneuroendocrinology; 1989; 14(1-2):137-43. PubMed ID: 2543999
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone.
Zampa GA; Benfenati F; Ghisoli E; Corbucci G; Vecchi P; Zini I; Battistini N; Agnati LF
J Endocrinol Invest; 1981; 4(4):423-9. PubMed ID: 7037921
[TBL] [Abstract][Full Text] [Related]
14. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
15. Involvement of alpha-adrenergic mechanisms in growth hormone release induced by opioid peptides in conscious rats.
Katakami H; Kato Y; Matsushita N; Hiroto S; Shimatsu A; Imura H
Neuroendocrinology; 1981 Sep; 33(3):129-35. PubMed ID: 6117022
[TBL] [Abstract][Full Text] [Related]
16. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade.
Giugliano D; Ceriello A; di Pinto P; Saccomanno F; Gentile S; Cappiapuoti F
Diabetes; 1982 Apr; 31(4 Pt 1):367-70. PubMed ID: 6295856
[TBL] [Abstract][Full Text] [Related]
17. Failure of naloxone to reduce the clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension.
Bramnert M; Hökfelt B
Acta Physiol Scand; 1983 Aug; 118(4):379-83. PubMed ID: 6314747
[TBL] [Abstract][Full Text] [Related]
18. Inverse control of growth hormone and prolactin secretion in clonidine-stimulated dairy cattle.
Borromeo V; Berrini A; Möller F; Secchi C
J Endocrinol; 1995 Aug; 146(2):271-7. PubMed ID: 7561639
[TBL] [Abstract][Full Text] [Related]
19. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers.
Mastrianni JA; Ingenito AJ
J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
